New biological approach

Old antibiotic could become valuable depression treatment

An antibiotic used mostly to treat acne has been found to improve the quality of life for people with major depression, in a clinical trial from Deakin University.

The results of the study showed that patients taking minocycline reported...
The results of the study showed that patients taking minocycline reported improved functioning, a better quality of life and showed improvements in anxiety symptoms.
Source: Pixabay

The trial added a daily dose of minocycline - a broad-spectrum antibiotic that has been prescribed since 1971 - to the usual treatment of 71 people experiencing major depression. The research team, led by Deakin's Centre for Innovation in Mental and Physical Health and Clinical Treatment within the School of Medicine, then compared the effects to a control group taking a placebo. The results - recently published in the Australian & New Zealand Journal of Psychiatry - showed that those taking minocycline reported improved functioning, a better quality of life and showed improvements in anxiety symptoms.

Lead researcher Dr. Olivia Dean said the research took a unique "biological" approach to treating depressive symptoms, which could inform future therapies. "There is evidence to suggest that people with major depressive disorder have increased levels of inflammation in their body," Dr Dean said. "Specifically, minocycline reduces brain inflammation in cell models, and thus we wanted to see if it was useful for people."

Safe and readily accessible

"We've found that using old medications for new purposes is very useful," she added. "Existing medications have known safety profiles and are readily accessible." In Australia, up to one in four people will experience depression over their lifetime. "Current antidepressants are useful, but many people find a gap between their experience before becoming unwell and their recovery following treatment," Dr Dean said. "We aim to fill this gap by providing new, biologically-based, treatments for depression."

The team is now in the process of applying for funding to expand the trial to a larger group. "We're also considering a study of minocycline for people with anxiety disorders, given what we have found in this study," Dr. Dean explained.
 

Source: Deakin University

16.07.2017

Read all latest stories

Related articles

Behaviour prediction

The psychology of taking risks

An anxious person will avoid risks whenever possible. This in itself is not exactly a surprise. However, researchers have found a way to visualize this process in the brain - with interesting…

Increasing prevalence

Oral antibiotics may raise risk of kidney stones - especially in kids

Pediatric researchers have found that children and adults treated with some oral antibiotics have a significantly higher risk of developing kidney stones. This is the first time that these medicines…

Small pill, great impact

Antibiotic resistance can be caused by small amounts of antibiotics

Antibiotic-resistant bacteria are a global and growing problem in health care. To be able to prevent further development of resistance developing, it is important to understand where and how…

Related products

Research use only (RUO)

Eppendorf - Mastercycler nexus X2

Eppendorf AG

Research use only (RUO)

SARSTEDT - Low DNA Binding Micro Tubes

SARSTEDT AG & CO.

Research use only (RUO)

Shimadzu - CLAM-2000

Shimadzu Europa GmbH